Answers are grounded in this paper and cite their sources.
Early recognition of severe forms of coronavirus disease 2019 (COVID-19) is essential for an opportune and effective intervention, reducing life-risking complications. An altered inflammatory immune response seems to be associated with COVID-19's pathogenesis and progression to severity. Here we demonstrate the utility of early nasopharyngeal swab samples for detection of the early expression of immune markers and the potential value of CCL2/MCP-1 in predicting disease outcome.
No takes yet. Share an insight, caveat, or question.
Sierra et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: